Alternative Expression & Products
The need to develop more complex biologics, whether they be proteins, cells, vectors or novel constructs, is forcing industry to investigate new production methods and pathways. The Alternative Expression & Products pipeline focuses on the engineering
of existing and emerging hosts, strains, vectors and cells to synthesize, express and manufacture novel products with commercially relevant application. Special attention will be paid to enabling technologies such as systems and synthetic biology,
microbial-based production, and, new for 2019, vector expression and production.
Engineering Genes, Vectors, Constructs, and Clones
Advances in Vector Production and Scale-Up for Cell Gene Therapy